Post-mortem cardiac-specific troponin-I (cTnI) to determine the cause of non-traumatic hemopericardium
- PMID: 40640648
- DOI: 10.1007/s12024-025-01043-2
Post-mortem cardiac-specific troponin-I (cTnI) to determine the cause of non-traumatic hemopericardium
Abstract
Hemopericardium is regularly seen at autopsy and post-mortem imaging. Once traumatic cases and resuscitation artefact are excluded, hemopericardium is almost always due to either ruptured myocardial infarction or aortic dissection. In this study, we explored whether post-mortem cardiac-specific troponin I (cTnI) can be helpful when autopsy is not feasible and post-mortem imaging findings are inconclusive. Post-mortem cTnI levels were compared between 46 cases with hemopericardium due to ruptured myocardial infarction (RMI), 38 cases of hemopericardium due to aortic dissection (AoD), and 44 cases of natural deaths without hemopericardium (controls). The results showed significantly higher cTnI levels in the RMI group (median 5,821 ng/L) compared to AoD (median 273 ng/L) and controls (median 95 ng/L). Receiver operating characteristic (ROC) analysis indicated that a cTnI threshold of 1,483 ng/L provided the best balance of sensitivity (87%) and specificity (90%) for distinguishing RMI from AoD. Levels of cTnI above 9688 ng/L were exclusively seen in RMI, whilst levels < 250 ng/L excluded this diagnosis. Calculated likelihood ratios demonstrated that higher levels of cTnI favour RMI over AoD, but substantial overlap between the cohorts limited the diagnostic value of intermediate cTnI values. Autopsy remains the gold standard for determining the cause of hemopericardium and cTnI testing is best reserved for cases in which an autopsy is not feasible.
Keywords: Aortic dissection; Autopsy; Biochemistry; Forensic medicine; Hemopericardium; Myocardial infarction; Pathology; Sudden cardiac death; Troponin; cTnI.
© 2025. Crown.
Conflict of interest statement
Declarations. Ethics approval and consent to participate: This study was approved by the Victorian Institute of Forensic Medicine (VIFM) Ethics Committee on the 26th of October 2022 (Project ID: 1247) which included a waiver of informed consent. Conflict of interest: The authors have no relevant financial or non-financial interests to disclose. No funding was received for conducting this study. Generative AI and AI-assisted technologies in the writing process: The authors used ChatGPT 3–5 to help improve the readability and language of the manuscript. The authors reviewed and edited any suggestions as needed and take full responsibility for the content of the published article.
References
-
- Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. Fourth universal definition of myocardial infarction (2018). Circulation. 2018;138(20):e618–51. - PubMed
-
- Sandoval Y, Apple FS, Mahler SA, Body R, Collinson PO, Jaffe AS, et al. High-sensitivity cardiac troponin and the 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR guidelines for the evaluation and diagnosis of acute chest pain. Circulation. 2022;146(7):569–81. - PubMed
-
- Byrne RA, Rossello X, Coughlan J, Barbato E, Berry C, Chieffo A, et al. 2023 ESC guidelines for the management of acute coronary syndromes: developed by the task force on the management of acute coronary syndromes of the European society of cardiology (ESC). Eur Heart Journal: Acute Cardiovasc Care. 2024;13(1):55–161.
-
- Barberi C, van den Hondel KE. The use of cardiac troponin T (cTnT) in the postmortem diagnosis of acute myocardial infarction and sudden cardiac death: A systematic review. Forensic Sci Int. 2018;292:27–38. - PubMed
-
- Beausire T, Faouzi M, Palmiere C, Fracasso T, Michaud K. High-sensitive cardiac troponin hs-TnT levels in sudden deaths related to atherosclerotic coronary artery disease. Forensic Sci Int. 2018;289:238–43. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
